Şahpolat Musa, Küçükdurmaz Zekeriya, Kavakçi Önder, Kurt Recep
Department of Psychiatry, Cumhuriyet University Faculty of Medicine Hospital, Sivas, Turkey.
Department of Cardiology, Cumhuriyet University Faculty of Medicine Hospital, Sivas Sivas, Turkey.
Noro Psikiyatr Ars. 2014 Jun;51(2):169-171. doi: 10.4274/npa.y7061. Epub 2014 Jun 1.
Paliperidone which is the active metabolite of risperidon is one of the novel antipsychotics. Controlled clinical studies proved its effectiveness on decreasing the positive and negative symptoms of schizophrenia. Some studies and case reports, reported its cardiovascular and cardiometabolic side effects. Cardiac tamponade, that may be mortal, wasn't reported as a side effect with paliperidone usage before. We present a 40 years old female with catatonic schizophrenia for eighteen years, whom was on 6 mg/day paliperidon for 3 years and presented with pericardial tamponade. We suggest that paliperdione may have cardiovascular and cardiometabolic side effects also in therapeutic doses.
帕利哌酮是利培酮的活性代谢产物,属于新型抗精神病药物。对照临床研究证实其对减轻精神分裂症的阳性和阴性症状有效。一些研究和病例报告指出了其心血管和心脏代谢方面的副作用。此前未报告过使用帕利哌酮会导致可能致命的心脏压塞这一副作用。我们报告一例40岁女性,患紧张型精神分裂症18年,服用帕利哌酮6毫克/天,共3年,出现了心包压塞。我们认为帕利哌酮在治疗剂量下也可能产生心血管和心脏代谢方面的副作用。